Top

Published in:

Open Access 01-12-2023 | Alzheimer's Disease | Review

Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies

Authors: Wei-tong Pan, Pan-miao Liu, Daqing Ma, Jian-jun Yang

Published in: Journal of Translational Medicine | Issue 1/2023

Abstract

Cognitive function is an important ability of the brain, but cognitive dysfunction can easily develop once the brain is injured in various neuropathological conditions or diseases. Photobiomodulation therapy is a type of noninvasive physical therapy that is gradually emerging in the field of neuroscience. Transcranial photobiomodulation has been commonly used to regulate neural activity in the superficial cortex. To stimulate deeper brain activity, advanced photobiomodulation techniques in conjunction with photosensitive nanoparticles have been developed. This review addresses the mechanisms of photobiomodulation on neurons and neural networks and discusses the advantages, disadvantages and potential applications of photobiomodulation alone or in combination with photosensitive nanoparticles. Photobiomodulation and its associated strategies may provide new breakthrough treatments for cognitive improvement.

Available only for authorised users

Petersen RC, et al. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275:214–28. https://doi.org/10.1111/joim.12190.CrossRefPubMedPubMedCentral

Nichols E, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88–106. https://doi.org/10.1016/s1474-4422(18)30403-4.CrossRef

Wu Y-T, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15:116–24. https://doi.org/10.1016/s1474-4422(15)00092-7.CrossRefPubMed

Chen S, et al. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics. Science. 2018;359:679–84. https://doi.org/10.1126/science.aaq1144.CrossRefPubMed

Barch DM, Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci. 2012;16:27–34. https://doi.org/10.1016/j.tics.2011.11.015.CrossRefPubMed

Chan D, et al. Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer’s disease. J Intern Med. 2021;290:993–1009. https://doi.org/10.1111/joim.13329.CrossRefPubMed

Alam A, Hana Z, Jin Z, Suen KC, Ma D. Surgery, neuroinflammation and cognitive impairment. EBioMedicine. 2018;37:547–56. https://doi.org/10.1016/j.ebiom.2018.10.021.CrossRefPubMedPubMedCentral

Vizcaychipi MP, et al. The therapeutic potential of atorvastatin in a mouse model of postoperative cognitive decline. Ann Surg. 2014;259:1235–44. https://doi.org/10.1097/SLA.0000000000000257.CrossRefPubMed

Zhu Y, et al. Inflammation disrupts the brain network of executive function after cardiac surgery. Ann Surg. 2021. https://doi.org/10.1097/SLA.0000000000005041.CrossRefPubMed

10.

Frohlich F, Riddle J. Conducting double-blind placebo-controlled clinical trials of transcranial alternating current stimulation (tACS). Transl Psychiatry. 2021;11:284. https://doi.org/10.1038/s41398-021-01391-x.CrossRefPubMedPubMedCentral

11.

Zhang J, et al. Non-invasive, opsin-free mid-infrared modulation activates cortical neurons and accelerates associative learning. Nat Commun. 2021;12:2730. https://doi.org/10.1038/s41467-021-23025-y.CrossRefPubMedPubMedCentral

12.

Monai H, et al. Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain. Nat Commun. 2016;7:11100. https://doi.org/10.1038/ncomms11100.CrossRefPubMedPubMedCentral

13.

Woollams AM, Madrid G, Lambon Ralph MA. Using neurostimulation to understand the impact of pre-morbid individual differences on post-lesion outcomes. Proc Natl Acad Sci U S A. 2017;114:12279–84. https://doi.org/10.1073/pnas.1707162114.CrossRefPubMedPubMedCentral

14.

Pitzschke A, et al. Red and NIR light dosimetry in the human deep brain. Phys Med Biol. 2015;60:2921–37. https://doi.org/10.1088/0031-9155/60/7/2921.CrossRefPubMed

15.

Wu X, et al. Deep-tissue photothermal therapy using laser illumination at NIR-IIa window. Nanomicro Lett. 2020;12:38. https://doi.org/10.1007/s40820-020-0378-6.CrossRefPubMedPubMedCentral

16.

Golovynska I, et al. Red and near-infrared light evokes Ca(2+) influx, endoplasmic reticulum release and membrane depolarization in neurons and cancer cells. J Photochem Photobiol B. 2021;214:112088. https://doi.org/10.1016/j.jphotobiol.2020.112088.CrossRefPubMed

17.

Zhang Y, et al. Recent progress on NIR-II photothermal therapy. Front Chem. 2021;9:728066. https://doi.org/10.3389/fchem.2021.728066.CrossRefPubMedPubMedCentral

18.

de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016. https://doi.org/10.1109/JSTQE.2016.2561201.CrossRefPubMedPubMedCentral

19.

Zivin JA, et al. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke. 2009;40:1359–64. https://doi.org/10.1161/STROKEAHA.109.547547.CrossRefPubMed

20.

Salehpour F, et al. Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: a review of literature. Photobiomodul Photomed Laser Surg. 2019;37:581–95. https://doi.org/10.1089/photob.2019.4676.CrossRefPubMed

21.

Golovynskyi S, et al. Optical windows for head tissues in near-infrared and short-wave infrared regions: approaching transcranial light applications. J Biophotonics. 2018;11:e201800141. https://doi.org/10.1002/jbio.201800141.CrossRefPubMed

22.

Kim H, Chung K, Lee S, Kim DH, Lee H. Near-infrared light-responsive nanomaterials for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8:23–45. https://doi.org/10.1002/wnan.1347.CrossRefPubMed

23.

Esenaliev RO, et al. Nano-pulsed laser therapy is neuroprotective in a rat model of blast-induced neurotrauma. J Neurotrauma. 2018;35:1510–22. https://doi.org/10.1089/neu.2017.5249.CrossRefPubMedPubMedCentral

24.

Zinchenko E, et al. Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease. Biomed Opt Express. 2019;10:4003–17. https://doi.org/10.1364/BOE.10.004003.CrossRefPubMedPubMedCentral

25.

Zhang D, Shen Q, Wu X, Xing D. Photobiomodulation therapy ameliorates glutamatergic dysfunction in mice with chronic unpredictable mild stress-induced depression. Oxid Med Cell Longev. 2021;2021:6678276. https://doi.org/10.1155/2021/6678276.CrossRefPubMedPubMedCentral

26.

Salehpour F, et al. Brain photobiomodulation therapy: a narrative review. Mol Neurobiol. 2018;55:6601–36. https://doi.org/10.1007/s12035-017-0852-4.CrossRefPubMedPubMedCentral

27.

Chen Y, De Taboada L, O’Connor M, Delapp S, Zivin JA. Thermal effects of transcranial near-infrared laser irradiation on rabbit cortex. Neurosci Lett. 2013;553:99–103. https://doi.org/10.1016/j.neulet.2013.07.049.CrossRefPubMed

28.

Rojas JC, Gonzalez-Lima F. Neurological and psychological applications of transcranial lasers and LEDs. Biochem Pharmacol. 2013;86:447–57. https://doi.org/10.1016/j.bcp.2013.06.012.CrossRefPubMed

29.

Jahan A, Nazari MA, Mahmoudi J, Salehpour F, Salimi MM. Transcranial near-infrared photobiomodulation could modulate brain electrophysiological features and attentional performance in healthy young adults. Lasers Med Sci. 2019;34:1193–200. https://doi.org/10.1007/s10103-018-02710-3.CrossRefPubMed

30.

Cassano P, et al. Selective photobiomodulation for emotion regulation: model-based dosimetry study. Neurophotonics. 2019;6:015004. https://doi.org/10.1117/1.NPh.6.1.015004.CrossRefPubMedPubMedCentral

31.

Salehpour F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review. Rev Neurosci. 2020;31:269–86. https://doi.org/10.1515/revneuro-2019-0063.CrossRefPubMedPubMedCentral

32.

Saltmarche AE, Naeser MA, Ho KF, Hamblin MR, Lim L. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report. Photomed Laser Surg. 2017;35:432–41. https://doi.org/10.1089/pho.2016.4227.CrossRefPubMedPubMedCentral

33.

Ma M, et al. Near-infrared target enhanced peripheral clearance of amyloid-beta in Alzheimer’s disease model. Biomaterials. 2021;276:121065. https://doi.org/10.1016/j.biomaterials.2021.121065.CrossRefPubMed

34.

Ortega-Martinez S, Palla N, Zhang X, Lipman E, Sisodia SS. Deficits in enrichment-dependent neurogenesis and enhanced anxiety behaviors mediated by expression of Alzheimer’s disease-linked Ps1 variants are rescued by microglial depletion. J Neurosci. 2019;39:6766–80. https://doi.org/10.1523/JNEUROSCI.0884-19.2019.CrossRefPubMedPubMedCentral

35.

Yuan J, et al. Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of Parkinson’s disease. Adv Mater. 2022;34:e2108435. https://doi.org/10.1002/adma.202108435.CrossRefPubMed

36.

Zhu G, et al. Phototherapy for cognitive function in patients with dementia: a systematic review and meta-analysis. Front Aging Neurosci. 2022;14:936489. https://doi.org/10.3389/fnagi.2022.936489.CrossRefPubMedPubMedCentral

37.

Chan AS, Lee TL, Yeung MK, Hamblin MR. Photobiomodulation improves the frontal cognitive function of older adults. Int J Geriatr Psychiatry. 2019;34:369–77. https://doi.org/10.1002/gps.5039.CrossRefPubMed

38.

Vargas E, et al. Beneficial neurocognitive effects of transcranial laser in older adults. Lasers Med Sci. 2017;32:1153–62. https://doi.org/10.1007/s10103-017-2221-y.CrossRefPubMedPubMedCentral

39.

Mitrofanis J, Henderson LA. How and why does photobiomodulation change brain activity? Neural Regen Res. 2020;15:2243–4. https://doi.org/10.4103/1673-5374.284989.CrossRefPubMedPubMedCentral

40.

Wang X, Tian F, Soni SS, Gonzalez-Lima F, Liu H. Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep. 2016;6:30540. https://doi.org/10.1038/srep30540.CrossRefPubMedPubMedCentral

41.

Zundorf G, Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal. 2011;14:1275–88. https://doi.org/10.1089/ars.2010.3359.CrossRefPubMedPubMedCentral

42.

Gonzalez-Reyes RE, Nava-Mesa MO, Vargas-Sanchez K, Ariza-Salamanca D, Mora-Munoz L. Involvement of astrocytes in Alzheimer’s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci. 2017;10:427. https://doi.org/10.3389/fnmol.2017.00427.CrossRefPubMedPubMedCentral

43.

Zomorrodi R, Loheswaran G, Pushparaj A, Lim L. Pulsed near infrared transcranial and intranasal photobiomodulation significantly modulates neural oscillations: a pilot exploratory study. Sci Rep. 2019;9:6309. https://doi.org/10.1038/s41598-019-42693-x.CrossRefPubMedPubMedCentral

44.

Salehpour F, Rasta SH. The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder. Rev Neurosci. 2017;28:441–53. https://doi.org/10.1515/revneuro-2016-0087.CrossRefPubMed

45.

Hamblin MR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018;94:199–212. https://doi.org/10.1111/php.12864.CrossRefPubMedPubMedCentral

46.

Karu TI. Effects of visible radiation on cultured cells. Photochem Photobiol. 1990;52:1089–98. https://doi.org/10.1111/j.1751-1097.1990.tb08450.x.CrossRefPubMed

47.

Karu TI. Cellular and molecular mechanisms of photobiomodulation (low-power laser therapy). IEEE J Sel Top Quantum Electron. 2014;20:143–8. https://doi.org/10.1109/jstqe.2013.2273411.CrossRef

48.

Johnstone DM, Moro C, Stone J, Benabid AL, Mitrofanis J. Turning on lights to stop neurodegeneration: the potential of near infrared light therapy in Alzheimer’s and Parkinson’s disease. Front Neurosci. 2015;9:500. https://doi.org/10.3389/fnins.2015.00500.CrossRefPubMed

49.

Levchenko SM, et al. Near-infrared irradiation affects lipid metabolism in neuronal cells, inducing lipid droplets formation. ACS Chem Neurosci. 2019;10:1517–23. https://doi.org/10.1021/acschemneuro.8b00508.CrossRefPubMed

50.

Passarella S. He–Ne laser irradiation of isolated mitochondria. J Photochem Photobiol B Biol. 1989. https://doi.org/10.1016/1011-1344(89)80090-9.CrossRef

51.

Hamblin MR. Photobiomodulation for Alzheimer’s disease: has the light dawned? Photonics. 2019. https://doi.org/10.3390/photonics6030077.CrossRefPubMedPubMedCentral

52.

Golovynska I, et al. Red and near-infrared light induces intracellular Ca(2+) flux via the activation of glutamate N-methyl-D-aspartate receptors. J Cell Physiol. 2019. https://doi.org/10.1002/jcp.28257.CrossRefPubMed

53.

Sharma SK, et al. Dose response effects of 810nm laser light on mouse primary cortical neurons. Lasers Surg Med. 2011;43:851–9. https://doi.org/10.1002/lsm.21100.CrossRefPubMedPubMedCentral

54.

Biswas R, et al. Low-level laser therapy with 850nm recovers salivary function via membrane redistribution of aquaporin 5 by reducing intracellular Ca(2+) overload and ER stress during hyperglycemia. Biochim Biophys Acta Gen Subj. 1862;1770–1780:2018. https://doi.org/10.1016/j.bbagen.2018.05.008.CrossRef

55.

Huang YY, Nagata K, Tedford CE, Hamblin MR. Low-level laser therapy (810nm) protects primary cortical neurons against excitotoxicity in vitro. J Biophotonics. 2014;7:656–64. https://doi.org/10.1002/jbio.201300125.CrossRefPubMed

56.

Moulton MJ, et al. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease-associated genes. Proc Natl Acad Sci U S A. 2021. https://doi.org/10.1073/pnas.2112095118.CrossRefPubMedPubMedCentral

57.

Liu L, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160:177–90. https://doi.org/10.1016/j.cell.2014.12.019.CrossRefPubMedPubMedCentral

58.

Huang YY, Nagata K, Tedford CE, McCarthy T, Hamblin MR. Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. J Biophotonics. 2013;6:829–38. https://doi.org/10.1002/jbio.201200157.CrossRefPubMed

59.

Ahmed NA, et al. Effect of three different intensities of infrared laser energy on the levels of amino acid neurotransmitters in the cortex and hippocampus of rat brain. Photomed Laser Surg. 2008;26:479–88. https://doi.org/10.1089/pho.2007.2190.CrossRefPubMed

60.

Zhang M, Frohlich F. Cell type-specific excitability probed by optogenetic stimulation depends on the phase of the alpha oscillation. Brain Stimul. 2022;15:472–82. https://doi.org/10.1016/j.brs.2022.02.014.CrossRefPubMed

61.

Yang M, Yang Z, Wang P, Sun Z. Current application and future directions of photobiomodulation in central nervous diseases. Neural Regen Res. 2021;16:1177–85. https://doi.org/10.4103/1673-5374.300486.CrossRefPubMed

62.

Berman MH, et al. Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition. J Neurol Neurosci. 2017. https://doi.org/10.21767/2171-6625.1000176.CrossRefPubMedPubMedCentral

63.

Wang X, et al. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: a broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017;37:3789–802. https://doi.org/10.1177/0271678X17691783.CrossRefPubMedPubMedCentral

64.

Maksimovich IV. Dementia and cognitive impairment reduction after laser transcatheter treatment of Alzheimer’s disease. World J Neurosci. 2015;05:189–203. https://doi.org/10.4236/wjns.2015.53021.CrossRef

65.

Carniglia L, et al. Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases. Mediators Inflamm. 2017;2017:5048616. https://doi.org/10.1155/2017/5048616.CrossRefPubMedPubMedCentral

66.

Khuman J, et al. Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice. J Neurotrauma. 2012;29:408–17. https://doi.org/10.1089/neu.2010.1745.CrossRefPubMedPubMedCentral

67.

Nizamutdinov D, et al. Transcranial near infrared light stimulations improve cognition in patients with dementia. Aging Dis. 2021;12:954–63. https://doi.org/10.14336/AD.2021.0229.CrossRefPubMedPubMedCentral

68.

Wu JH, et al. Effect of low-level laser stimulation on EEG. Evid Based Complement Alternat Med. 2012;2012:951272. https://doi.org/10.1155/2012/951272.CrossRefPubMedPubMedCentral

69.

Barrett DW, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013;230:13–23. https://doi.org/10.1016/j.neuroscience.2012.11.016.CrossRefPubMed

70.

Blanco NJ, Maddox WT, Gonzalez-Lima F. Improving executive function using transcranial infrared laser stimulation. J Neuropsychol. 2017;11:14–25. https://doi.org/10.1111/jnp.12074.CrossRefPubMed

71.

Blanco NJ, Saucedo CL, Gonzalez-Lima F. Transcranial infrared laser stimulation improves rule-based, but not information-integration, category learning in humans. Neurobiol Learn Mem. 2017;139:69–75. https://doi.org/10.1016/j.nlm.2016.12.016.CrossRefPubMed

72.

Zhang Z, Shen Q, Wu X, Zhang D, Xing D. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Abeta levels in Alzheimer’s disease models. Aging Cell. 2020;19:e13054. https://doi.org/10.1111/acel.13054.CrossRefPubMed

73.

Cho GM, et al. Photobiomodulation using a low-level light-emitting diode improves cognitive dysfunction in the 5XFAD mouse model of Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. 2020;75:631–9. https://doi.org/10.1093/gerona/gly240.CrossRefPubMed

74.

Henderson TA, Morries LD. Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain? Neuropsychiatr Dis Treat. 2015;11:2191–208. https://doi.org/10.2147/NDT.S78182.CrossRefPubMedPubMedCentral

75.

Xuan W, Huang L, Hamblin MR. Repeated transcranial low-level laser therapy for traumatic brain injury in mice: biphasic dose response and long-term treatment outcome. J Biophotonics. 2016;9:1263–72. https://doi.org/10.1002/jbio.201500336.CrossRefPubMedPubMedCentral

76.

Mocciaro E, et al. Non-invasive transcranial nano-pulsed laser therapy ameliorates cognitive function and prevents aberrant migration of neural progenitor cells in the hippocampus of rats subjected to traumatic brain injury. J Neurotrauma. 2020;37:1108–23. https://doi.org/10.1089/neu.2019.6534.CrossRefPubMed

77.

Naeser MA, et al. Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. J Neurotrauma. 2014;31:1008–17. https://doi.org/10.1089/neu.2013.3244.CrossRefPubMedPubMedCentral

78.

Moro C, et al. Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice. J Neurosurg. 2014;120:670–83. https://doi.org/10.3171/2013.9.JNS13423.CrossRefPubMed

79.

Suto T, Fukuda M, Ito M, Uehara T, Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol Psychiatry. 2004;55:501–11. https://doi.org/10.1016/j.biopsych.2003.09.008.CrossRefPubMed

80.

Cardoso FDS, Gonzalez-Lima F, Gomes da Silva S. Photobiomodulation for the aging brain. Ageing Res Rev. 2021;70:101415. https://doi.org/10.1016/j.arr.2021.101415.CrossRefPubMed

81.

Liebert A, et al. Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study. BMC Neurol. 2021;21:256. https://doi.org/10.1186/s12883-021-02248-y.CrossRefPubMedPubMedCentral

82.

Aarsland D, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13:217–31. https://doi.org/10.1038/nrneurol.2017.27.CrossRefPubMedPubMedCentral

83.

Li S, Dong J, Cheng C, Le W. Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions. J Neural Transm (Vienna). 2016;123:1279–99. https://doi.org/10.1007/s00702-016-1603-9.CrossRefPubMed

84.

Leisman G, Machado C, Machado Y, Chinchilla-Acosta M. Effects of low-level laser therapy in autism spectrum disorder. Adv Exp Med Biol. 2018;1116:111–30. https://doi.org/10.1007/5584_2018_234.CrossRefPubMed

85.

Kim HY, Seo K, Jeon HJ, Lee U, Lee H. Application of functional near-infrared spectroscopy to the study of brain function in humans and animal models. Mol Cells. 2017;40:523–32. https://doi.org/10.14348/molcells.2017.0153.CrossRefPubMedPubMedCentral

86.

Zorkina Y, et al. Nano carrier drug delivery systems for the treatment of neuropsychiatric disorders: advantages and limitations. Molecules. 2020. https://doi.org/10.3390/molecules25225294.CrossRefPubMedPubMedCentral

87.

Jain KK. Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (Lond). 2012;7:1225–33. https://doi.org/10.2217/nnm.12.86.CrossRefPubMed

88.

Sagar V, Nair M. Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders. Expert Opin Drug Deliv. 2018;15:137–52. https://doi.org/10.1080/17425247.2017.1297794.CrossRefPubMed

89.

Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12:991–1003. https://doi.org/10.1038/nmat3776.CrossRefPubMed

90.

Karimi M, et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev. 2016;45:1457–501. https://doi.org/10.1039/c5cs00798d.CrossRefPubMedPubMedCentral

91.

Agrahari V. The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches. Neural Regen Res. 2017;12:197–200. https://doi.org/10.4103/1673-5374.200796.CrossRefPubMedPubMedCentral

92.

Bansal A, Zhang Y. Photocontrolled nanoparticle delivery systems for biomedical applications. Acc Chem Res. 2014;47:3052–60. https://doi.org/10.1021/ar500217w.CrossRefPubMed

93.

Bao Z, Liu X, Liu Y, Liu H, Zhao K. Near-infrared light-responsive inorganic nanomaterials for photothermal therapy. Asian J Pharm Sci. 2016;11:349–64. https://doi.org/10.1016/j.ajps.2015.11.123.CrossRef

94.

Liu B, et al. Functional nanomaterials for near-infrared-triggered cancer therapy. Biomater Sci. 2016;4:890–909. https://doi.org/10.1039/c6bm00076b.CrossRefPubMed

95.

Paviolo C, Stoddart PR. Gold nanoparticles for modulating neuronal behavior. Nanomaterials (Basel). 2017. https://doi.org/10.3390/nano7040092.CrossRefPubMedPubMedCentral

96.

Mahor A, et al. Carbon-based nanomaterials for delivery of biologicals and therapeutics: a cutting-edge technology. C. 2021. https://doi.org/10.3390/c7010019.CrossRef

97.

Yang Y, et al. Semiconducting polymer nanoparticles as theranostic system for near-infrared-II fluorescence imaging and photothermal therapy under safe laser fluence. ACS Nano. 2020;14:2509–21. https://doi.org/10.1021/acsnano.0c00043.CrossRefPubMed

98.

Cheon YA, Bae JH, Chung BG. Reduced graphene oxide nanosheet for chemo-photothermal therapy. Langmuir. 2016;32:2731–6. https://doi.org/10.1021/acs.langmuir.6b00315.CrossRefPubMed

99.

Croissant JG, Guardado-Alvarez TM. Photocracking silica: tuning the plasmonic photothermal degradation of mesoporous silica encapsulating gold nanoparticles for cargo release. Inorganics. 2019. https://doi.org/10.3390/inorganics7060072.CrossRef

100.

Álvarez YD, Pellegrotti JV, Stefani FD. In use of nanoparticles in neuroscience neuromethods Ch. Chapter 16. 2018. p. 269–291

101.

Sanchez-Lopez E, et al. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization. J Nanobiotechnology. 2018;16:32. https://doi.org/10.1186/s12951-018-0356-z.CrossRefPubMedPubMedCentral

102.

Wen G, et al. Effective Phototheranostics of brain tumor assisted by near-infrared-II light-responsive semiconducting polymer nanoparticles. ACS Appl Mater Interfaces. 2020;12:33492–9. https://doi.org/10.1021/acsami.0c08562.CrossRefPubMed

103.

Liu W, Dong X, Liu Y, Sun Y. Photoresponsive materials for intensified modulation of Alzheimer’s amyloid-beta protein aggregation: a review. Acta Biomater. 2021;123:93–109. https://doi.org/10.1016/j.actbio.2021.01.018.CrossRefPubMed

104.

Wang P, et al. Au/Ag nanobox-based near-infrared surface-enhanced Raman scattering for hydrogen sulfide sensing. ACS Appl Bio Mater. 2019;2:417–23. https://doi.org/10.1021/acsabm.8b00634.CrossRefPubMed

105.

Lee JW, Jung H, Cho HH, Lee JH, Nam Y. Gold nanostar-mediated neural activity control using plasmonic photothermal effects. Biomaterials. 2018;153:59–69. https://doi.org/10.1016/j.biomaterials.2017.10.041.CrossRefPubMed

106.

Liu D, et al. Using near-infrared enhanced thermozyme and scFv dual-conjugated Au nanorods for detection and targeted photothermal treatment of Alzheimer’s disease. Theranostics. 2019;9:2268–81. https://doi.org/10.7150/thno.30649.CrossRefPubMedPubMedCentral

107.

Ge K, et al. Gold nanorods with spatial separation of ceo2 deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer’s disease. ACS Appl Mater Interfaces. 2022;14:3662–74. https://doi.org/10.1021/acsami.1c17861.CrossRefPubMed

108.

Yang C, Park S. Nanomaterials-assisted thermally induced neuromodulation. Biomed Eng Lett. 2021;11:163–70. https://doi.org/10.1007/s13534-021-00193-w.CrossRefPubMedPubMedCentral

109.

Liu J, et al. Antibody-conjugated gold nanoparticles as nanotransducers for second near-infrared photo-stimulation of neurons in rats. Nano Converg. 2022;9:13. https://doi.org/10.1186/s40580-022-00304-y.CrossRefPubMedPubMedCentral

110.

Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851. https://doi.org/10.1016/j.addr.2021.113851.CrossRefPubMed

111.

Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. https://doi.org/10.1002/wnan.1450.CrossRefPubMedPubMedCentral

112.

Movahedi F, Hu RG, Becker DL, Xu C. Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics. Nanomedicine. 2015;11:1575–84. https://doi.org/10.1016/j.nano.2015.03.006.CrossRefPubMed

113.

Amstad E, et al. Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett. 2011;11:1664–70. https://doi.org/10.1021/nl2001499.CrossRefPubMed

114.

Miranda D, Lovell JF. Mechanisms of light-induced liposome permeabilization. Bioeng Transl Med. 2016;1:267–76. https://doi.org/10.1002/btm2.10032.CrossRefPubMedPubMedCentral

115.

Mathiyazhakan M, Wiraja C, Xu C. A concise review of gold nanoparticles-based photo-responsive liposomes for controlled drug delivery. Nanomicro Lett. 2018;10:10. https://doi.org/10.1007/s40820-017-0166-0.CrossRefPubMed

116.

Wu G, et al. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc. 2008;130:8175–7. https://doi.org/10.1021/ja802656d.CrossRefPubMedPubMedCentral

117.

Mathiyazhakan M, et al. In situ synthesis of gold nanostars within liposomes for controlled drug release and photoacoustic imaging. Sci China Mater. 2016;59:892–900. https://doi.org/10.1007/s40843-016-5101-3.CrossRef

118.

Sonkar R, et al. Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics. Mater Sci Eng C Mater Biol Appl. 2021;120:111652. https://doi.org/10.1016/j.msec.2020.111652.CrossRefPubMed

119.

Chang K, et al. Highly stable conjugated polymer dots as multifunctional agents for photoacoustic imaging-guided photothermal therapy. ACS Appl Mater Interfaces. 2018;10:7012–21. https://doi.org/10.1021/acsami.8b00759.CrossRefPubMed

120.

Lyu Y, et al. Intraparticle molecular orbital engineering of semiconducting polymer nanoparticles as amplified theranostics for in vivo photoacoustic imaging and photothermal therapy. ACS Nano. 2016;10:4472–81. https://doi.org/10.1021/acsnano.6b00168.CrossRefPubMed

121.

Li J, Pu K. Semiconducting polymer nanomaterials as near-infrared photoactivatable protherapeutics for cancer. Acc Chem Res. 2020;53:752–62. https://doi.org/10.1021/acs.accounts.9b00569.CrossRefPubMed

122.

Tortiglione C, Antognazza MR, et al. Semiconducting polymers are light nanotransducers in eyeless animals. Sci Adv. 2017;3: e1601699.CrossRefPubMedPubMedCentral

123.

Li J, Pu K. Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation. Chem Soc Rev. 2019;48:38–71. https://doi.org/10.1039/c8cs00001h.CrossRefPubMed

124.

Geng J, et al. Biocompatible conjugated polymer nanoparticles for efficient photothermal tumor therapy. Small. 2015;11:1603–10. https://doi.org/10.1002/smll.201402092.CrossRefPubMed

125.

Yang K, et al. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv Mater. 2012;24:5586–92. https://doi.org/10.1002/adma.201202625.CrossRefPubMed

126.

Gholami Derami H, et al. Reversible photothermal modulation of electrical activity of excitable cells using polydopamine nanoparticles. Adv Mater. 2021;33:e2008809. https://doi.org/10.1002/adma.202008809.CrossRefPubMed

127.

Wu X, et al. Tether-free photothermal deep-brain stimulation in freely behaving mice via wide-field illumination in the near-infrared-II window. Nat Biomed Eng. 2022. https://doi.org/10.1038/s41551-022-00862-w.CrossRefPubMedPubMedCentral

128.

Li B, et al. Photothermal modulation of depression-related ion channel function through conjugated polymer nanoparticles. Adv Funct Mater. 2021. https://doi.org/10.1002/adfm.202010757.CrossRefPubMedPubMedCentral

129.

Qi W, et al. Light-controlled precise delivery of NIR-responsive semiconducting polymer nanoparticles with promoted vascular permeability. Adv Healthc Mater. 2021;10:e2100569. https://doi.org/10.1002/adhm.202100569.CrossRefPubMed

130.

Jiang Y, et al. Neural stimulation in vitro and in vivo by photoacoustic nanotransducers. Matter. 2021;4:654–74. https://doi.org/10.1016/j.matt.2020.11.019.CrossRef

131.

Maiti D, Tong X, Mou X, Yang K. Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol. 2018;9:1401. https://doi.org/10.3389/fphar.2018.01401.CrossRefPubMed

132.

Akhavan O, Ghaderi E, Shirazian SA. Near infrared laser stimulation of human neural stem cells into neurons on graphene nanomesh semiconductors. Colloids Surf B Biointerfaces. 2015;126:313–21. https://doi.org/10.1016/j.colsurfb.2014.12.027.CrossRefPubMed

133.

Li M, Yang X, Ren J, Qu K, Qu X. Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer’s disease. Adv Mater. 2012;24:1722–8. https://doi.org/10.1002/adma.201104864.CrossRefPubMed

134.

Zhang M, et al. Graphene oxide based theranostic platform for T1-weighted magnetic resonance imaging and drug delivery. ACS Appl Mater Interfaces. 2013;5:13325–32. https://doi.org/10.1021/am404292e.CrossRefPubMed

135.

Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 2013;42:530–47. https://doi.org/10.1039/c2cs35342c.CrossRefPubMed

136.

Pattnaik S, Swain K, Lin Z. Graphene and graphene-based nanocomposites: biomedical applications and biosafety. J Mater Chem B. 2016;4:7813–31. https://doi.org/10.1039/c6tb02086k.CrossRefPubMed

137.

Sun X, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1:203–12. https://doi.org/10.1007/s12274-008-8021-8.CrossRefPubMedPubMedCentral

138.

Robinson JT, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011;133:6825–31. https://doi.org/10.1021/ja2010175.CrossRefPubMed

139.

Xiong S, et al. Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against Parkinson’s disease. Biomater Sci. 2021;9:1705–15. https://doi.org/10.1039/d0bm01765e.CrossRefPubMed

140.

Hsieh TY, et al. Neurotensin-conjugated reduced graphene oxide with multi-stage near-infrared-triggered synergic targeted neuron gene transfection in vitro and in vivo for neurodegenerative disease therapy. Adv Healthc Mater. 2016;5:3016–26. https://doi.org/10.1002/adhm.201600647.CrossRefPubMed

141.

Bramini M, et al. Interfacing graphene-based materials with neural cells. Front Syst Neurosci. 2018;12:12. https://doi.org/10.3389/fnsys.2018.00012.CrossRefPubMedPubMedCentral

142.

Qin Y, et al. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Acta Biomater. 2015;17:201–9. https://doi.org/10.1016/j.actbio.2015.01.026.CrossRefPubMed

143.

Li R, et al. Folate and iron difunctionalized multiwall carbon nanotubes as dual-targeted drug nanocarrier to cancer cells. Carbon. 2011;49:1797–805. https://doi.org/10.1016/j.carbon.2011.01.003.CrossRef

144.

Song L, Shi J, Lu J, Lu C. Structure observation of graphene quantum dots by single-layered formation in layered confinement space. Chem Sci. 2015;6:4846–50. https://doi.org/10.1039/c5sc01416f.CrossRefPubMedPubMedCentral

145.

Kumawat MK, Thakur M, Gurung RB, Srivastava R. Graphene quantum dots for cell proliferation, nucleus imaging, and photoluminescent sensing applications. Sci Rep. 2017;7:15858. https://doi.org/10.1038/s41598-017-16025-w.CrossRefPubMedPubMedCentral

146.

Cheng YJ, et al. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. ACS Appl Mater Interfaces. 2015;7:9078–87. https://doi.org/10.1021/acsami.5b00752.CrossRefPubMed

147.

Pistone A, et al. Tunable doxorubicin release from polymer-gated multiwalled carbon nanotubes. Int J Pharm. 2016;515:30–6. https://doi.org/10.1016/j.ijpharm.2016.10.010.CrossRefPubMed

148.

Tian Z, et al. Metal-organic framework/graphene quantum dot nanoparticles used for synergistic chemo- and photothermal therapy. ACS Omega. 2017;2:1249–58. https://doi.org/10.1021/acsomega.6b00385.CrossRefPubMedPubMedCentral

149.

Yang L, et al. Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring. Theranostics. 2021;11:1269–94. https://doi.org/10.7150/thno.49672.CrossRefPubMedPubMedCentral

150.

de Jesus Fonseca EG, et al. Study of transcranial therapy 904 nm in experimental model of stroke. Lasers Med Sci. 2019;34:1619–25. https://doi.org/10.1007/s10103-019-02758-9.CrossRefPubMed

151.

Lund DJ, Edsall P, Stuck BE. Spectral dependence of retinal thermal injury. J Laser Appl. 2008;20:76–82. https://doi.org/10.2351/1.2900534.CrossRef

152.

Wang J, et al. Retinal safety of near-infrared lasers in cataract surgery. J Biomed Opt. 2012;17:95001–95001. https://doi.org/10.1117/1.JBO.17.9.095001.CrossRefPubMed

Title: Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies
Authors: Wei-tong Pan
Pan-miao Liu
Daqing Ma
Jian-jun Yang
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Alzheimer's Disease
Alzheimer's Disease
Laser
Published in: Journal of Translational Medicine / Issue 1/2023
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-023-03988-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis

Ligand-based adoptive T cell targeting CA125 in ovarian cancer

Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study

Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey

Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage